Impacts of the COVID-19 pandemic on breast cancer screening and early diagnosis in Brazil
PDF (Portuguese (Brazil))

Keywords

Breast cancer
COVID-19
Mammography
Early diagnosis
Screening

How to Cite

Impacts of the COVID-19 pandemic on breast cancer screening and early diagnosis in Brazil. (2026). Electronic Journal Collection Health, 26(11), e24967. https://doi.org/10.25248/reas.e24967.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze the scientific evidence regarding the impacts of the COVID-19 pandemic on breast cancer screening and early diagnosis in Brazil. Methods: This is an integrative literature review conducted in the Virtual Health Library and PubMed databases, including primary studies published between 2020 and 2025 in Portuguese and English. After applying the eligibility criteria, 12 studies composed the final sample. Results: A significant reduction in mammography screening during the pandemic period was identified, as well as diagnostic delays, decreased detection of cases at early stages, and a proportional increase in advanced-stage diagnoses. In addition, important impacts on oncological care and increased regional inequalities in access to health services were observed. Difficulties related to the temporary suspension of elective services, overload of the healthcare system, and the population’s fear of seeking in-person care were also identified. Final considerations: It can be considered that the pandemic negatively impacted breast cancer screening and early diagnosis in Brazil, reinforcing the need for resilient strategies, reorganization of health services, and strengthening of public policies to ensure continuity of care during health crisis scenarios.

PDF (Portuguese (Brazil))

References

ANTONINIM, et al. Two Years Post-COVID-19: An Ecologic Study Evaluating the Impact on Brazil’s Mammographic Screening Program. Cancer Control, 2024; 31: 1-6.

2. AROMATARIS E, MUNN Z. JBI Manual for Evidence Synthesis. Adelaide: Joanna Briggs Institute, 2020.

BRASIL. Lei nº 15.284, de 2025. Dispõe sobre a ampliação do rastreamento mamográfico no Sistema Único de Saúde. Diário Oficial da União, Brasília, 2025.

BRASIL. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Controle do câncer de mama: documento de consenso. Rio de Janeiro: INCA, 2022.

BRASIL. Ministério da Saúde. Sistema de Informação do Câncer (SISCAN). Brasília: Ministério da Saúde, 2024.

BRAUN V, CLARKE V. Using thematic analysis in psychology. Qualitative Research in Psychology, 2006; 3(2): 77-101.

DEMARCHI PKH, et al. O impacto da pandemia da COVID-19 no volume de mamografias no Brasil: uma análise de previsão baseada nos números históricos. Revista Brasileira de Cancerologia, 2022; 68(3): 1-8.

DOS SANTOS DIAS PD, et al. Repercussions of the COVID-19 pandemic on breast cancer actions in a Brazilian state. Investigación y Educación en Enfermería, 2024; 42(2): 1-9.

DOWNES MJ, et al. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open, 2016; 6(12): e011458.

FURLAM TO, et al. COVID-19 e rastreamento do câncer de mama no Brasil: uma análise comparativa dos períodos pré-pandêmico e pandêmico. Ciência & Saúde Coletiva, 2023; 28(1): 223-230.

HYEDA A, et al. The negative impact of the COVID-19 pandemic on breast cancer care in Brazil: a time series study in regions with different human development indices. BMC Public Health, 2024; 24(1): 3047.

HYEDA A, et al. The negative impact of the COVID-19 pandemic on breast cancer tackle in Brazil's public and private healthcare system: time series study between 2014 and 2022. BMC Health Services Research, 2024; 24(1): 1335.

MOTERANI JÚNIOR NJW, et al. Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings. Revista da Associação Médica Brasileira, 2022; 68(6): 842-846.

NEGRAO EMS, et al. The COVID-19 Pandemic Impact on Breast Cancer Diagnosis: A Retrospective Study. Revista Brasileira de Ginecologia e Obstetrícia, 2022; 44(9): 871-877.

PAGE MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021; 372: n71.

ROCHA AFBM, et al. COVID-19 and Breast Cancer in Brazil. International Journal of Public Health, 2023; 68: 1605485.

SOLLA NEGRAO EM, et al. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area. Journal of Medical Screening, 2023; 30(1): 42-46.

STEVANATO KP, et al. Impact of COVID-19 on Breast Cancer Screening. Asian Pacific Journal of Cancer Prevention, 2024; 25(8): 2703-2710.

TACHIBANA BMT, et al. The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil. Einstein (São Paulo), 2021; 19: 1-7.

WHITTEMORE R, KNAFL K. The integrative review: updated methodology. Journal of Advanced Nursing, 2005; 52(5): 546-553.

WORLD HEALTH ORGANIZATION. Breast cancer. Geneva: WHO, 2024.

WORLD HEALTH ORGANIZATION. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer, 2020.